metadata toggle
Presentation
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 75 mg tablet contains:
Active substance:
Cefalexin …………………………………………….75 mg (as Cefalexin Monohydrate)
Excipients:
Qualitative composition of excipients and other constituents
Crospovidone
Mannitol
Starch pregelantinised
Croscarmellose sodium
Collodial anhydrous silica
Collodial hydrated silica
Povidone K30
Microcrystalline cellulose (type A)
Poultry liver powder
Magnesium stearate
Microcrystalline cellulose (type B)
Creamy oblong tablet with small brown spots marked with a score-line. The tablets can be divided into halves.
Each 300 mg tablet contains:
Active substance:
Cefalexin ………………………………………………….300 mg (as Cefalexin Monohydrate)
Excipients:
Qualitative composition of excipients and other constituents
Crospovidone
Mannitol
Starch pregelantinised
Croscarmellose sodium
Collodial anhydrous silica
Collodial hydrated silica
Povidone K30
Microcrystalline cellulose (type A)
Poultry liver powder
Magnesium stearate
Microcrystalline cellulose (type B)
Creamy oblong tablet with small brown spots marked with a score-line. The tablets can be divided into halves.
Each 600 mg tablet contains:
Active substance:
Cefalexin………………………………………………….600 mg (as Cefalexin Monohydrate)
Excipients:
Qualitative composition of excipients and other constituents
Crospovidone
Mannitol
Starch pregelantinised
Croscarmellose sodium
Collodial anhydrous silica
Collodial hydrated silica
Povidone K30
Microcrystalline cellulose (type A)
Poultry liver powder
Magnesium stearate
Microcrystalline cellulose (type B)
Creamy oblong tablet with small brown spots marked with a score-line. The tablets can be divided into halves.